Letter to the Editor
Chemoprevention of basal cell carcinoma: reply from authors
I. Hoorens,
I. Hoorens
Department of Dermatology, University Hospital Ghent, De Pintelaan 185, 9000 Gent, Belgium
Search for more papers by this author L. Brochez,
Corresponding Author
L. Brochez
Department of Dermatology, University Hospital Ghent, De Pintelaan 185, 9000 Gent, Belgium
Correspondence: Lieve Brochez.
E-mail: [email protected]
Search for more papers by this author
I. Hoorens,
I. Hoorens
Department of Dermatology, University Hospital Ghent, De Pintelaan 185, 9000 Gent, Belgium
Search for more papers by this author L. Brochez,
Corresponding Author
L. Brochez
Department of Dermatology, University Hospital Ghent, De Pintelaan 185, 9000 Gent, Belgium
Correspondence: Lieve Brochez.
E-mail: [email protected]
Search for more papers by this author
First published: 07 October 2016
No abstract is available for this article.
References
- 1Ali FR, Craythorne EE, Al-Niaimi F. Chemoprevention of basal cell carcinoma. Br J Dermatol 2016. doi: 10.1111/bjd.14937.
- 2Chen AC, Martin AJ, Choy B et al. A phase 3 randomized trial of nicotinamide for skin-cancer chemoprevention. N Engl J Med 2015; 373: 1618–26.
- 3Elmets CA, Viner JL, Pentland AP et al. Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trial. J Natl Cancer Inst 2010; 102: 1835–44.
- 4Green A, Williams G, Neale R et al. Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial. Lancet 1999; 354: 723–9.
- 5Green AC, Williams GM, Logan V, Strutton GM. Reduced melanoma after regular sunscreen use: randomized trial follow-up. J Clin Oncol 2011; 29: 257–63.
- 6Flohil SC, Seubring I, van Rossum MM et al. Trends in basal cell carcinoma incidence rates: a 37-year Dutch observational study. J Invest Dermatol 2013; 133: 913–18.
- 7Flohil SC, de Vries E, Neumann HA et al. Incidence, prevalence and future trends of primary basal cell carcinoma in the Netherlands. Acta Derm Venereol 2011; 91: 24–30.
